BackTravere Therapeutics Overview

Travere Therapeutics Current Cash

Track Travere Therapeutics's current cash ($78M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$78.36M
↑ 26.60% YoYΔ $16.46M vs prior year quarter

Peer average

Loading

Travere Therapeutics Current Cash History

Loading

Travere Therapeutics vs. peers: Current Cash Comparison

Loading

Travere Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Travere Therapeutics (TVTX) FAQ

Travere Therapeutics (TVTX) currently reports a current cash of $78M as of March 2026. That compares with $62M in the prior-year period — up 26.6% year over year. Use the charts on this page to explore Travere Therapeutics's current cash history and peer comparisons.

Travere Therapeutics's current cash increased from $62M to $78M — a 26.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Travere Therapeutics reported $78M in current cash as of March 2026. That compares with $62M in the prior-year period — up 26.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $78M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Travere Therapeutics, and consider following TVTX for alerts when major investors trade the stock.

Travere Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $78M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TVTX with unrelated industries.